
Abhinav Deol
@abhinav_deol
MD
ID: 4487134512
07-12-2015 15:22:18
2,2K Tweet
562 Takipçi
512 Takip Edilen


Great time interacting and learning from Nitin Jain about CLL and ALL.PGI Clinical Hematology and Medical Oncology A marathon session spaning half a day , insightful, engaging, and a true exchange of ideas.

Happy to share, I have received YIP award, SOHO 2025 for old yet unanswered question: Len vs Mel oncogenic potential ! Grateful to my mentors Vijendra Singh Dr. Jeffrey Zonder Geetha Krishnamoorthy Karmanos Hematology/Oncology Fellowship and deevyaparekh for collaboration!



Honored to be named a 2025 Hematology Research All-Star! This recognition by @Avant-garde Health highlights the top 5% of physicians for impactful research. Grateful to my collaborators and mentors, this is a shared achievement! BU Amyloidosis Center Boston Medical Center Boston U Chobanian & Avedisian School of Medicine


Late post ! Had a great time ISTH 2025. Meeting mentors, having oral sessions ! Icing on the cake is receiving early career investigator award ! I owe to both my mentors Vijendra Singh Rushad Patell.



I'm looking forward to participating in Karmanos Cancer Institute Annual Lymphoma Symposium and discussing recent advances in CNS lymphomas. #lymphoma #lymsm


So honored to receive this prestigious award by ECOG-ACRIN Cancer Research Group kudos to all investigators/staff who work hard to conduct trials globally! PrECOG Naomi Haas MJ Jean Hoffman-Censits Dr. Tom Lynch Nicole D. Fleming MD Amer Zeidan MBBS,MHS عامر زيدان Manmeet Ahluwalia, MD, MBA, FASCO Shilpa Gupta OncoAlert Tian Zhang, MD, MHS

Here’s to new beginnings. Excited for the new chapter and all the wonderful things that are yet to happen. Winship Cancer Institute of Emory University


Huge thanks to Suresh S. Ramalingam, MD, FASCO, and Sagar Lonial MD Winship Cancer Institute of Emory University for an outstanding 25th #DDHO2025 and a lively debate with Dr. Ashesh Jani on the best approach to treating oligometastatic hormone sensitive prostate cancer. 🔎Takeaway: Personalization is key. Volume and risk

Our manuscript using single cell RNA sequencing to compare two CD19 CAR T cell products, axi-cel and tisa-cel is online at JITC! Frederick L. Locke Moffitt Cancer Center jitc.bmj.com/content/13/7/e… . Our findings (thread):

Thrilled to share that I’ve joined Saint Luke's, BJC HealthCare, and UMKC as a GI medical oncologist! Fellowship ✅—I’m incredibly grateful for all the support from my amazing mentors and colleagues at Mayo Clinic. Couldn’t have asked for a better training experience!


Chimeric Antigen Receptor T-cell Therapy for Richter Transformation: A CIBMTR analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy astctjournal.org/article/S2666-… Mehdi Hamadani, MD Mazyar Shadman, MD MPH



Eight Aspects of Oncology That Aren’t Taught in Training: Tips for How to Handle Them. Great read and highly useful for all early career oncologists, hem/onc aspirants and fellows, Congratulations and thank you for valuable tips ! Ibrahim Azar, MD connection.asco.org/do/eight-aspec…
